PGFG
MRK icon

Pine Grove Financial Group’s Merck MRK Stock Holding History

Pine Grove Financial Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Sell
3,428
-294
-8% -$34.4K 0.04% 140
2026
Q1 		$448K Buy
3,722
+1,259
+51% +$145K 0.05% 124
2025
Q4 		$259K Buy
+2,463
New +$231K 0.03% 165

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pine Grove Financial Group's MRK Position: Q2 2026 in Review

Pine Grove Financial Group reduced its Merck (MRK) stake by 7.9% in Q2 2026, selling an estimated $34.4K and leaving 3,428 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #140.

Pine Grove Financial Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $448K in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pine Grove Financial Group held 3,428 shares of Merck worth $441K as of Q2 2026.
  • Pine Grove Financial Group sold 294 Merck shares in Q2 2026, an estimated $34.4K.
  • Merck made up 0.04% of Pine Grove Financial Group's portfolio in Q2 2026, its #140 holding.
  • Pine Grove Financial Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Pine Grove Financial Group's Merck position peaked at $448K in Q1 2026.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pine Grove Financial Group's 13F filing for Q2 2026, filed 2 Sep 2026.